Delivery Order SPE2DB22D2211-SPE2DB25FSCTP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $54,803.42 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.91 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,421.82 on June 26, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. The contract is set to conclude on June 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an HIV treatment...
- The Defense Logistics Agency awarded a $27,168.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was issued on September 19, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) valued at $23,129.73. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 16, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, representing the type of specialized...
- The Defense Logistics Agency awarded a delivery order valued at $7,882.67 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, was competitively awarded without set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,116.14 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract includes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $31,805.90 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on June 3, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $15,696.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCTPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,725.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 12, 2025, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the breadth of pharmaceutical products procured through federal medical supply channels. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp regularly fulfills competitively awarded delivery orders across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/12/25 |